Miniatura

Fitxers

632371.pdf (1.48 MB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2013-11-21

Tots els drets reservats

Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/108603

Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1101/gr.152132

Resum

Chronic lymphocytic leukemia (CLL) has heterogeneous clinical and biological behavior. Whole-genome and -exome sequencing has contributed to the characterization of the mutational spectrum of the disease, but the underlying transcriptional profile is still poorly understood. We have performed deep RNA sequencing in different subpopulations of normal B-lymphocytes and CLL cells from a cohort of 98 patients, and characterized the CLL transcriptional landscape with unprecedented resolution. We detected thousands of transcriptional elements differentially expressed between the CLL and normal B cells, including protein-coding genes, noncoding RNAs, and pseudogenes. Transposable elements are globally derepressed in CLL cells. In addition, two thousand genes-most of which are not differentially expressed-exhibit CLL-specific splicing patterns. Genes involved in metabolic pathways showed higher expression in CLL, while genes related to spliceosome, proteasome, and ribosome were among the most down-regulated in CLL. Clustering of the CLL samples according to RNA-seq derived gene expression levels unveiled two robust molecular subgroups, C1 and C2. C1/C2 subgroups and the mutational status of the immunoglobulin heavy variable (IGHV) region were the only independent variables in predicting time to treatment in a multivariate analysis with main clinico-biological features. This subdivision was validated in an independent cohort of patients monitored through DNA microarrays. Further analysis shows that B-cell receptor (BCR) activation in the microenvironment of the lymph node may be at the origin of the C1/C2 differences.

Matèries

Leucèmia limfocítica crònica, Cèl·lules B, Expressió gènica, Genètica molecular

Matèries (anglès)

Chronic lymphocytic leukemia, B cells, Gene expression, Molecular genetics

Citació

Col·leccions

Articles publicats en revistes (Fonaments Clínics)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Citació

FERREIRA, Pedro g., JARES GERBOLES, Pedro, RICO, Daniel, GÓMEZ LÓPEZ, Gonzalo, MARTÍNEZ TRILLOS, Alejandra, VILLAMOR I CASAS, Neus, ECKER, Simone, GONZÁLEZ-PÉREZ, Abel, KNOWLES, David g., MONLONG, Jean, JOHNSON, Rory, QUESADA, Victor, DJEBALI, Sarah, PAPASAIKAS, Panagiotis, LÓPEZ-GUERRA, Mónica, COLOMER PUJOL, Dolors, ROYO MORENO, Cristina, CAZORLA, Maite, PINYOL, Magda, CLOT RAZQUIN, Guillem, AYMERICH GREGORIO, Marta, ROZMAN, María, KULIS, Marta, TAMBORERO NOGUERA, David, GOUIN, Anaïs, BLANC, Julie, GUT, Marta, GUT, Ivo g., PUENTE, Xose s., PISANO, David g., MARTÍN-SUBERO, José ignacio, LÓPEZ BIGAS, Núria, LÓPEZ GUILLERMO, Armando, VALENCIA, Alfonso, LÓPEZ-OTIN, Carlos, CAMPO GÜERRI, Elias, GUIGÓ SERRA, Roderic. Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia. _Genome Research_. 2013. Vol. 24, núm. 2, pàgs. 212-226. [consulta: 10 de gener de 2026]. ISSN: 1088-9051. [Disponible a: https://hdl.handle.net/2445/108603]

Exportar metadades

JSON - METS

Compartir registre